Antibody Analytics
Adele Hannigan is currently serving as the Chief Business Officer at Antibody Analytics, leading the Commercial Department to grow and evolve the company. Prior to this role, Adele held positions such as Director of Strategy and Head of Knowledge Transfer at TC BioPharm Limited. Adele also has experience as a Business Development Manager and Process Development Manager, with a focus on cell therapy and scientific research projects. Their background includes roles as a Cancer Research Scientist at EnGeneIC Ltd and as a Post-Doctoral Research Scientist at Cancer Research UK Beatson Institute. Adele holds a Master's Degree in Chemistry with Industrial Experience, a Ph.D. in investigating carcinogenesis, and another Master's Degree in Molecular Functions in Disease.
Antibody Analytics
At Antibody Analytics we believe that scientists deserve the best data, and patients deserve the best drugs. Led by a group of talented and engaged scientists, we look at biological problems in an openminded way to deliver beautifully designed, developed and qualified bioassays. We have developed a comprehensive portfolio of assays and platforms that can be tailored to support even the most complex of drug pipelines. Whether designing and developing bespoke bioassays or offering routine analysis on our already established assay platforms, Antibody Analytics has an exceptional track record of delivering beautiful results. http://www.antibodyanalytics.com